Thromboxane-A Synthase, antagonists & inhibitors

Accession Number

DBCAT001297

Description

Not Available

Drugs

Drug	Drug Description
Ridogrel	Used as an adjunctive therapy to induce thrombolysis in patients suffering acute myocardial infarction.
Dazoxiben	Not Available
Imidazole	Not Available
Ozagrel	Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

Drugs & Drug Targets

Drug	Target	Type
Ridogrel	Thromboxane-A synthase	target
Ridogrel	Thromboxane A2 receptor	target
Dazoxiben	Thromboxane-A synthase	target
Imidazole	Monomeric sarcosine oxidase	target
Imidazole	Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase	target
Imidazole	Myoglobin	target
Imidazole	Nitric oxide synthase, inducible	target
Imidazole	Adenylate kinase 2, mitochondrial	target
Imidazole	Serine/threonine-protein kinase pim-1	target
Imidazole	Isopentenyl-diphosphate Delta-isomerase	target
Imidazole	Alpha,alpha-trehalose-phosphate synthase [UDP-forming]	target
Imidazole	Leukotriene A-4 hydrolase	target
Imidazole	Gephyrin	target
Imidazole	Acyl carrier protein	target
Imidazole	Sensor protein FixL	target
Imidazole	Cytochrome c	target
Imidazole	Circadian clock protein KaiB	target
Imidazole	Histidinol dehydrogenase	target
Imidazole	Acyl-CoA thioesterase I	target
Imidazole	A/G-specific adenine glycosylase	target
Imidazole	YopE regulator	target
Imidazole	Unconventional myosin-Ie	target
Imidazole	Meiotic recombination protein DMC1/LIM15 homolog	target
Imidazole	Guanine deaminase	target
Imidazole	Endo-1,4-beta-xylanase A	target
Imidazole	Bacterial hemoglobin	target
Imidazole	Molybdenum cofactor biosynthesis protein B	target
Imidazole	Uracil-DNA glycosylase inhibitor	target
Imidazole	Recombination protein RecR	target